Crizotinib-Related Aseptic Abscesses in Lung Adenocarcinoma and <i>ROS1</i>-Gene Rearrangement: A Case Report

Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We re...

Full description

Saved in:
Bibliographic Details
Main Authors: Thamires Oliveira-Silva, Camila Naegele-Bazzanella, Mauro Zukin, Nicolle Cavalcante, Antônio Alexandre de-Oliveira-Siciliano, Jaime Araújo-Oliveira-Neto, Clarissa Baldotto
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2025-01-01
Series:Brazilian Journal of Oncology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1805098
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Crizotinib is a multi-tyrosine kinase inhibitor (mTKI) with efficacy in treating c-ROS oncogene 1-positive non-small cell lung cancer (NSCLC). The association between this TKI and the development of renal cysts is well established, although data on the formation of aseptic abscesses is scarce. We report a case of a patient with ROS1-positive NSCLC treated with crizotinib who developed multiple renal and extrarenal cysts and aseptic abscesses associated with a quick resolution of these lesions after the discontinuation of the TKI therapy. We aim to report a rare presentation of a drug-related adverse event with an unusual behavior.
ISSN:2526-8732